Introduction:
Thermo Fisher Scientific Inc., has recently announced its plans to expand its facility for increasing capacity of viral vector development and manufacturing services located at Plainville, Mass, USA.
Features:
The project with an investment of $180 million, doubles the size of the company's commercial viral vector capacity to support the rising demand of development and manufacturing of gene therapies and vaccines.
The project is expected to provide around 200 job opportunities.The state-of-the-art facility will have digital connectivity and capabilities to drive operational efficiencies, high quality, data visibility and advanced operator training.
The new site comprises of laboratory and production sites, with warehousing and office space also on-site. The site attracts diverse workforce of scientists, quality control specialists and production teams.
This expansion accelerates the cell and gene therapy innovation, thus giving hope to more patients everywhere.
Construction of the facility is expected to be completed by 2022.
Specifications:
| Name | Thermo Fisher Scientific Inc |
| Type | Expansion |
| Budget | $180 million |
| Year | 2022 |
